Kyle Hebert
Overview
Explore the profile of Kyle Hebert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siegel S, DeWolf S, Schmalz J, Saber W, Dong J, Martens M, et al.
medRxiv
. 2025 Mar;
PMID: 40061351
Successful hematopoietic cell transplant requires immunosuppression to prevent graft-versus-host disease (GVHD), a lethal, T-cell-mediated post-transplant complication. The phase 3 BMT CTN 1703 trial demonstrated superior GVHD-free/relapse-free survival for post-transplant cyclophosphamide...
2.
Takahashi T, Watkins B, Bratrude B, Neuberg D, Hebert K, Betz K, et al.
Transplant Cell Ther
. 2024 Apr;
31(2):109.e1-109.e13.
PMID: 38583802
Although unrelated-donor (URD) hematopoietic cell transplantation (HCT) is associated with many toxicities, a detailed analysis of adverse events, as defined by the Common Terminology Criteria for Adverse Events (CTCAE), has...
3.
Gorfinkel L, Raghunandan S, Watkins B, Hebert K, Neuberg D, Bratrude B, et al.
Bone Marrow Transplant
. 2024 Feb;
59(5):680-687.
PMID: 38383714
Chronic graft-versus-host-disease (cGVHD) is divided into two subtypes: classic (absence of acute GVHD features) and overlap cGVHD ('ocGVHD'), in which both chronic and acute GVHD clinical features are present simultaneously....
4.
Raghunandan S, Gorfinkel L, Bratrude B, Suessmuth Y, Hebert K, Neuberg D, et al.
Bone Marrow Transplant
. 2023 Aug;
58(11):1260-1263.
PMID: 37580396
No abstract available.
5.
Wachter F, Hebert K, Pikman Y, Yang J, Shah B, Bledsoe J, et al.
Pediatr Blood Cancer
. 2023 Jun;
:e30530.
PMID: 37369986
Background: The role of cytoreduction prior to hematopoietic cell transplant (HCT) for patients with pediatric myelodysplastic syndrome (MDS) and related disorders remains unclear. Procedure: We performed a single-center retrospective analysis...
6.
Gale R, Hinterberger W, Young N, Gennery A, Dvorak C, Hebert K, et al.
Res Sq
. 2023 Feb;
PMID: 36778326
Background: Aplastic anaemia has diverse aetiologies. Distinguishing between these is, in part, testable by analyzing results of haematopoietic cells transplants between genetically-identical twins one of whom has aplastic anaemia. Objective:...
7.
Richardson P, Jacobus S, Weller E, Hassoun H, Lonial S, Raje N, et al.
N Engl J Med
. 2022 Jun;
387(2):132-147.
PMID: 35660812
Background: In patients with newly diagnosed multiple myeloma, the effect of adding autologous stem-cell transplantation (ASCT) to triplet therapy (lenalidomide, bortezomib, and dexamethasone [RVD]), followed by lenalidomide maintenance therapy until...
8.
Cancio M, Hebert K, Kim S, Aljurf M, Olson T, Anderson E, et al.
Transplant Cell Ther
. 2021 Oct;
28(2):101.e1-101.e6.
PMID: 34670170
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare, inherited bone marrow failure syndrome. Hematopoietic stem cell transplantation (HSCT) is considered a curative treatment option, but existing descriptions of patient and transplant...
9.
Marsh R, Hebert K, Kim S, Dvorak C, Aquino V, Baker K, et al.
J Allergy Clin Immunol
. 2021 Aug;
149(3):1097-1104.e2.
PMID: 34375618
Background: Allogeneic hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis (HLH) disorders is associated with substantial morbidity and mortality. Objective: The effect of conditioning regimen groups of varying intensity on outcomes after...
10.
Watkins B, Qayed M, McCracken C, Bratrude B, Betz K, Suessmuth Y, et al.
J Clin Oncol
. 2021 Jan;
39(17):1865-1877.
PMID: 33449816
Purpose: Severe (grade 3-4) acute graft-versus-host disease (AGVHD) is a major cause of death after unrelated-donor (URD) hematopoietic cell transplant (HCT), resulting in particularly high mortality after HLA-mismatched transplantation. There...